Single-dose radiotherapy treatment improves cancer recovery

February 5, 2014 by Louisa Frew
Single-dose radiotherapy treatment improves cancer recovery
“The current options are either partial or radical mastectomy as many women aren’t able to spend six weeks away from their support system for treatment. Credit: Ed Uthman

Western Australian breast cancer patients are helping to boost evidence for a single-dose radiotherapy regime, with researchers hoping to provide a new option that is both effective and more convenient.

Since 2004, 385 WA women have been recruited for the targeted intraoperative radiotherapy (TARGIT) trial, a randomised non-inferiority trial based at the University College London, involving almost 3000 participants from 33 centres in 11 countries.

University of Notre Dame Australia chair of biostatistics and trial statistician Professor Max Bulsara says conventional radiotherapy is given externally and irradiates the whole breast, requiring 15 to 30 hospital visits over five to six weeks.

"TARGIT is a one-off 30-minute radiotherapy carried out when the lump is removed and while still under anaesthesia, that removes the need for conventional treatment," he says.

A recent five year analysis of local recurrence and mortality revealed no significant difference between all-cause and across the two treatment groups.

The analysis also showed significantly fewer non- deaths with TARGIT versus conventional therapy.

Prof Bulsara says these results in conjunction with previous analysis report fewer side-effects and added economic and healthcare resource benefits, make TARGIT a suitable alternative therapy.

"With three machines in Australia we are fortunate to have two machines in WA, but at this stage they are only for private patients or those on the trial," he says.

"It's not yet available for the general public but we are hopeful this will change.

"We think the results are definitely mature enough for there to be serious consideration to change in practice."

Prof Bulsara says there is a global momentum for introducing TARGIT therapy, with countries with potentially long travel times to tertiary medical services, as well as developing countries, likely to reap the most benefit.

"TARGIT would be particularly beneficial in countries like Australia where rural cancer patients currently have a much worse outcome than their urban counterparts," he says.

"The current options are either partial or radical mastectomy as many women aren't able to spend six weeks away from their support system for treatment.

"If this [treatment] becomes available, they would be able to have breast-saving surgery and at the one visit."

With recruitment targets met in June 2012, the group now plan to continue with long-term follow-up of recurrence rates, and all-cause and cancer-specific mortality.

They will also conduct a detailed economic analysis and designing other spin-off trials to maximise the effectiveness of the treatment.

Explore further: Single-dose radiotherapy during surgery 'effective in preventing breast cancer return'

Related Stories

Single-dose radiotherapy during surgery 'effective in preventing breast cancer return'

November 12, 2013
A single dose of targeted radiotherapy delivered during or just after surgery could benefit some women undergoing treatment for early breast cancer, two new European studies suggest.

Avoiding radiotherapy is an option for some older patients with breast cancer

December 11, 2013
Omission of radiotherapy is a reasonable option for women age 65 or older who receive hormone therapy after breast-conserving surgery for hormone receptor-positive, axillary node-negative breast cancer, according to results ...

Breast conserving treatment with radiotherapy reduces risk of local recurrence

September 18, 2013
Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcinoma in situ (DCIS). ...

'One-stop' radiation treatment might offer breast cancer care alternative

November 12, 2013
(HealthDay)—Some women with early breast cancer might benefit from a "one-and-done" treatment, in which they receive a single dose of targeted radiation therapy during the surgery that removes their tumor.

Study confirms fewer, bigger doses of radiotherapy benefit breast cancer patients

December 7, 2012
A lower total dose of radiotherapy, delivered in fewer, larger treatments, is as safe and effective at treating early breast cancer as the international standard dose, according to the 10-year follow-up results of a major ...

Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study

January 30, 2014
Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.

Recommended for you

Vitamin C may encourage blood cancer stem cells to die

August 17, 2017
Vitamin C may "tell" faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers. This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.